Quinn Anthony G.
CIK 0001532219
President & CEODirector
Filings
10
Latest Feb 9, 2026
Issuers covered
2
Showing
10 of 10
Page 1
Track record
4 of 7 open-market trades scored (57% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 75% | +4.4% | +8.2% | +22.1% | -21.2% |
| 90 days | 4 | 0% | -64.0% | -62.2% | -60.5% | -71.1% |
| 180 days | 4 | 0% | -75.3% | -74.2% | -73.3% | -79.3% |
| 365 days | 4 | 0% | -82.9% | -82.4% | -81.0% | -85.9% |
Issuers
Companies where Quinn Anthony G. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GBIO | Generation Bio Co. | 7 | Feb 9, 2026 |
| SYRE | Spyre Therapeutics, Inc. | 3 | Mar 18, 2022 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|